Natus Medical Incorporated (NASDAQ:BABY) Files An 8-K Submission of Matters to a Vote of Security Holders

Natus Medical Incorporated (NASDAQ:BABY) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07.

Submission of Matters to a Vote of Security Holders

On June22, 2018, Natus Medical Incorporated (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”).

On June 26, 2018, American Election Services, the independent inspector of elections for the Annual Meeting, delivered its final vote tabulation that certified the voting results for each of the matters set forth below that were submitted to a vote at the Annual Meeting.

As of the close of business on May 7, 2018, the record date for the Annual Meeting, 34,069,930 shares of Company's common stock (“Common Stock”), were outstanding and entitled to vote. 30,829,073 share of Common Stock were voted in person or by proxy at the Annual Meeting, representing 90.49% of the shares entitle to be voted.

The final voting results for the Annual Meeting are as follows:

Proposal 1: Election of Directors

Nominee

For

Doris E. Engibous

4,717,220

Robert S. Weiss

4,710,990

Lisa Wipperman Heine (Voce Nominee)

20,665,024

Joshua H. Levine (Voce Nominee)

20,645,288

Proposal 2: Ratification of KPMG as Auditors

For

Against

Abstain

Broker

Non-Votes

30,260,977

57,098

510,998

818,888

Proposal 3:Advisory Approval of the Company's Executive Compensation

For

Against

Abstain

Broker

Non-Votes

22,092,056

7,446,567

471,562

818,888

Proposal 4:Vote to Repeal Bylaw Amendments Adopted by the Company's Board of Directors After March 22, 2012

For

Against

Abstain

Broker

Non-Votes

25,357,276

4,212,382

440,527

818,888

Proposal 5:Vote to Remove Robert A. Gunst from the Board

For

Against

Abstain

Broker

Non-Votes

7,108,317

13,590,574

323,611

818,888

Proposal 6:Vote to Elect Marg G. Gilreath to Fill the Vacancy in the Board Caused by the Removal of Mr. Gunst

For

Against

Abstain

Broker

Non-Votes

6,942,398

13,765,771

314,333

818,888

No other matters were considered or voted upon at the meeting.


About Natus Medical Incorporated (NASDAQ:BABY)

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company’s segment is neurology and newborn care product families. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It is organized into two strategic business units: Neurology and Newborn Care.

An ad to help with our costs